T2 Biosystems, Inc.
TTOO
$0.1315
-$0.0005-0.38%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.12M | -8.96M | -13.53M | -10.34M | -15.43M |
| Total Depreciation and Amortization | 59.00K | 62.00K | 64.00K | 74.00K | 262.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 333.00K | -433.00K | 2.38M | 1.37M | 4.76M |
| Change in Net Operating Assets | 3.47M | 93.00K | -593.00K | -523.00K | -2.99M |
| Cash from Operations | -6.25M | -9.24M | -11.68M | -9.42M | -13.39M |
| Capital Expenditure | -- | -- | -- | -26.00K | -13.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -26.00K | -13.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.09M | 7.28M | 2.20M | 812.00K | 21.70M |
| Repurchase of Common Stock | 0.00 | 0.00 | -1.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -62.00K |
| Cash from Financing | 4.09M | 7.28M | 2.20M | 812.00K | 21.64M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.16M | -1.96M | -9.48M | -8.63M | 8.24M |
